Filing Details
- Accession Number:
- 0001628280-24-049421
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-11-27 18:24:42
- Reporting Period:
- 2024-11-25
- Accepted Time:
- 2024-11-27 18:24:42
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1337013 | Infusystem Holdings Inc | INFU | Surgical & Medical Instruments & Apparatus (3841) | 203341405 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1706994 | Richard Dilorio | C/O Infusystem Holdings, Inc. 3851 West Hamlin Road Rochester Hills MI 48309 | Chief Executive Officer | Yes | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2024-11-25 | 20,000 | $9.32 | 436,659 | No | 4 | S | Direct | |
Common Stock | Disposition | 2024-11-26 | 14,602 | $8.91 | 422,057 | No | 4 | S | Direct | |
Common Stock | Disposition | 2024-11-27 | 5,398 | $8.87 | 416,659 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 456,659 | Direct |
Footnotes
- This total includes an additional 885 shares acquired recently through the Company's Employee Stock Purchase Plan
- The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person on August 23, 2024.
- The price reported in Column 4 is a weighted average price. These shares reported herein were sold in multiple transactions. The reporting person undertakes to provide to the Issuer, and security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.